Shuxia Zhang

机构：Ministry of Education of the People's Republic of China, North University of China, Chinese Academy of Medical Sciences & Peking Union Medical College, State Administration of Traditional Chinese Medicine of the People's Republic of China, Lanzhou University · ORCID：0000-0001-6557-568X

发表论文 44 篇 · 总被引 1038 次 · h-index 18

代表论文

• Notoginsenoside R1 alleviates cerebral ischemia/reperfusion injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway through microbiota-gut-brain axis (2024 · Phytomedicine · 被引 71)
• A novel ratiometric aptasensor based on dual-emission fluorescent signals and the conformation of G-quadruplex for OTA detection (2022 · Sensors and Actuators B Chemical · 被引 63)
• Protective effects of Gypenoside XVII against cerebral ischemia/reperfusion injury via SIRT1-FOXO3A- and Hif1a-BNIP3-mediated mitochondrial autophagy (2022 · Journal of Translational Medicine · 被引 59)
• Mitochondria-Related Ferroptosis Drives Cognitive Deficits in Neonatal Mice Following Sevoflurane Administration (2022 · Frontiers in Medicine · 被引 50)
• New insight into gut microbiota and their metabolites in ischemic stroke: A promising therapeutic target (2023 · Biomedicine & Pharmacotherapy · 被引 35)
• Folium Ginkgo extract and tetramethylpyrazine sodium chloride injection (Xingxiong injection) protects against focal cerebral ischaemia/reperfusion injury via activating the Akt/Nrf2 pathway and inhibiting NLRP3 inflammasome activation (2022 · Pharmaceutical Biology · 被引 32)